Global Cell Expansion (Stem Cell Research, Regenerative Medicine, Clinical Diagnostics) Market - Forecast to 2019

The global cell expansion market involves various products that help in mass production specific cells from a tissue or a sample. This market is driven by several factors which include increasing cancer research, technological advancements, high prevalence of chronic diseases, and growth in government investments. The relatively untapped Asian market and increasing number of stem cell research have opened an array of opportunities for growth of the cell expansion market. However, high cost of instruments and ethical concerns are expected to restrain the growth of this market. 

The global cell expansion market is expected to reach $14.8 billion by 2019 from $6.0 billion in 2014, growing at a CAGR of 19.7% from 2014 to 2019. The cell expansion market is segmented on the basis of product, cell type, application, end-user, and geography. 

On the basis of product, the cell expansion market is segmented into consumables and instruments. In 2014, the consumables segment is expected to account for the largest share of the global cell expansion market, by product. The high share can be attributed to the extensive requirement of media in cell expansion process. The consumables market is further divided into reagents, media and serum, and disposables. The instrument market is segmented into automated cell expansion systems, bioreactors and supporting equipment. Supporting equipment include centrifuges, flow cytometers, filtration systems, incubators, microscopes, laminar air flow cabinets and others. The others segment includes strainers, water baths, vortex mixers, pipettes, and cell counters. The bioreactors segment is further categorized into micro carrier bioreactor and perfusion or hollow fiber bioreactors. 

The cell expansion market by cell type is bifurcated into human cells and animal cells. The human cell market is further sub segmented into stem cells and differentiated cells. The stem cell expansion market is poised to witness the highest growth in the cell expansion market, by cell type, owing to the increasing government funding of stem cell research and investments by companies to boost the research in cancer. 

Prominent players in the cell expansion market are Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.),Corning Incorporation (U.S.), GE Healthcare (U.K.),Merck Millipore (U.S.), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Sigma-Aldrich Corporation (U.S.), Terumo BCT (U.S.),and Thermo Fisher Scientific Inc. (U.S.).